Kim Stratton

Kim Stratton

Chief Executive Officer at CENTOGENE N.V.

Net worth: 129 227 $ as of 31/05/2024

62 year
Health Technology
Commercial Services
Process Industries

Profile

Ms. Kim Stratton is an Independent Director at Novonesis A/S and a Chief Executive Officer at Centogene NV.
She is on the Board of Directors at Novonesis A/S, Recordati SpA, European Federation of Pharmaceutical Industries & Assns and Vifor Pharma Management AG.
Ms. Stratton was previously employed as a Chief Executive Officer by Orphazyme A/S, an Independent Director by Vifor Pharma AG, a Vice Chairman by Novozymes A/S, a Head-International Commercial by Shire International GmbH, a Head-Group Country Management & External Affairs by Novartis AG, a Head-United Kingdom Respiratory Business by AstraZeneca PLC, a Head-Marketing by Bristol Myers Squibb Co., a Sales Representative by GlaxoSmithKline Investments Pty Ltd., and a Chief Operating Officer by Novartis UK Ltd.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/05/2024 348,322 ( 1.20% ) 129 227 $ 31/05/2024

Kim Stratton active positions

CompaniesPositionStart
RECORDATI Director/Board Member 16/12/2021
CENTOGENE N.V. Chief Executive Officer 20/12/2021
Director/Board Member -
Director/Board Member -
All active positions of Kim Stratton

Former positions of Kim Stratton

CompaniesPositionEnd
ORPHAZYME A/S Chief Executive Officer 10/12/2020
NOVARTIS AG Public Communications Contact 01/03/2013
Chief Operating Officer -
Corporate Officer/Principal -
VIFOR PHARMA Director/Board Member -
See the detail of Kim Stratton's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kim Stratton's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
NOVARTIS AG

Health Technology

ASTRAZENECA PLC

Health Technology

BRISTOL-MYERS SQUIBB COMPANY

Health Technology

ORPHAZYME A/S

Health Technology

RECORDATI

Health Technology

CENTOGENE N.V.

Commercial Services

Private companies7

Health Technology

Process Industries

Health Technology

Commercial Services

Distribution Services

Health Technology

Health Technology

See company connections